Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sirolimus 2 mg Tablets Under Fed Conditions
NCT02296762Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Feb 2010
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sirolimus in organ transplant rejection (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve. Started Feb 2010; status: completed.
02
Drugs
sirolimus
03
Conditions
organ transplant rejection
Beyond the preview
Go deeper on NCT02296762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296762.